AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Delcath Systems Inc
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001S81551
14.42▼ 0.33 (-2.24%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
14.75
Day's Range
14.33 – 14.73
52-Week Range
8.12 – 17.42
Volume
326.4K
Avg Volume
328.9K
Share Statistics
Shares Outstanding
Employees
156
Exchange
XNAS
Listed
2000-10-19
Share count as of July 31, 2026

Delcath Systems Inc (DCTH) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Delcath Systems Inc (DCTH)
What is Delcath Systems Inc's Market Cap?
Delcath Systems Inc's Market Cap is $500.4M, based on as-reported figures from SEC (XBRL) filings.
What is Delcath Systems Inc's Trailing P/E?
Delcath Systems Inc's Trailing P/E is 940.5×, based on as-reported figures from SEC (XBRL) filings.
What is Delcath Systems Inc's Price / Sales?
Delcath Systems Inc's Price / Sales is 5.2×, based on as-reported figures from SEC (XBRL) filings.
What is Delcath Systems Inc's Revenue (TTM)?
Delcath Systems Inc's Revenue (TTM) is $95.4M, based on as-reported figures from SEC (XBRL) filings.
What is Delcath Systems Inc's Net Income (TTM)?
Delcath Systems Inc's Net Income (TTM) is $532.0K, based on as-reported figures from SEC (XBRL) filings.
What is Delcath Systems Inc's EBITDA?
Delcath Systems Inc's EBITDA is -$1.5M, based on as-reported figures from SEC (XBRL) filings.
What is Delcath Systems Inc's Diluted EPS (TTM)?
Delcath Systems Inc's Diluted EPS (TTM) is 0.02, based on as-reported figures from SEC (XBRL) filings.
What is Delcath Systems Inc's EBITDA Margin?
Delcath Systems Inc's EBITDA Margin is -1.5%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · DCTHAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Product revenue
YoY growth+20.6%+26.3%+37.3%+83.6%
Cost of goods sold
Gross profit
% of revenue89.8%85.1%85.5%87.2%
Operating expenses:
Research and development expenses
Selling, general and administrative expenses
Total operating expenses
% of revenue81.5%91.6%96.0%89.1%
Operating income
% of revenue8.2%-6.5%-10.5%-1.9%
Interest income
Other expense
Income before income taxes
Income tax expense
Net income
% of revenue9.2%-4.3%-9.1%4.0%
Basic income per common share (in dollars per share)
Diluted income per common share (in dollars per share)